APA (7th ed.) Citation

I, W., B, L., J, S., B, T., L, L., S, A., . . . P, G. (2023). Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population. Asia-Pacific journal of clinical oncology, 19(1), 214. https://doi.org/10.1111/ajco.13807

Chicago Style (17th ed.) Citation

I, Walpole, et al. "Use and Outcomes from Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Ductal Adenocarcinoma in an Australasian Population." Asia-Pacific Journal of Clinical Oncology 19, no. 1 (2023): 214. https://doi.org/10.1111/ajco.13807.

MLA (9th ed.) Citation

I, Walpole, et al. "Use and Outcomes from Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Ductal Adenocarcinoma in an Australasian Population." Asia-Pacific Journal of Clinical Oncology, vol. 19, no. 1, 2023, p. 214, https://doi.org/10.1111/ajco.13807.